ABSTRACT. A potential in vitvo model of varicella-zoster virus (VZV) latency was developed. Dissociated human dorsal root ganglion cultures were infected with VZV and maintained for 1 wk in the presence of bromovinyl arabinosy1 uracil, a potent inhibitor of VZV. Seven to 21 d after removing the inhibitor (214 d after infection), the cells were trypsinized, passed to monolayers of human embryonic lung fibroblasts, and observed for VZV reactivation as indicated by typical cytopathic effects and the appearance of VZV antigens. VZV reactivated from 56% of the cultures containing both neurons and satellite cells but not from cultures specifically enriched for either neurons, satellite cells, or ganglion-derived fibroblasts. The failure to isolate VZV from cell suspensions that were sonicated before cocultivation with fibroblasts indicated that infectious VZV was not present before reactivation. Moreover, immunohistochemical and immunoprecipitation studies revealed no VZV-specific antigens in any cultures before the reactivation stimulus. VZV antigens were detected after trypsinization and cocultivation. These findings suggest that cultures containing both neurons and satellite cells provide a model system for VZV persistence that possesses many properties of a latent infection. (Pediatr Res 32: 699-703,1992) Abbreviations VZV, varicella-zoster virus HSV, herpes simplex virus NGF, nerve growth factor HELF, human embryonic lung fibroblast CPE, cytopathic effect DRG, dorsal root ganglion DMEM, Dulbecco's modified essential medium EMEM, Eagle's minimal essential medium FUDR, fluorodeoxyuridine BVaraU, bromovinyl arabinosyl uracil pfu, plaque forming units VZV, which produces latent infection of human DRG during primary infection (varicella), can reactivate many years later to produce herpes zoster. The sites of latency were initially assumed to be the DRG and trigeminal ganglia, on the basis of the characteristic dermatomal distribution of herpes zoster (1-3) and the detection of VZV within the ganglia during the acute phase of herpes zoster (4, 5). However, numerous attempts to recover VZV from DRG and trigeminal ganglia of adult cadavers have all failed, in contrast to the frequent recovery of HSV from trigeminal and sacral ganglia (6, 7).
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These sites of VZV latency were established, finally, by detecting VZV nucleic acids in human ganglia harvested at autopsy from individuals who died without active infection (8-1 1). However, in situ hybridization studies using VZV-specific probes have yielded conflicting data concerning the cellular location of the latent VZV and the prevalence of infected cells within these ganglia (8, 10, 12, 13) .
A model of VZV latency was approached in adult rats by S.C. paraspinous injection of virus and its subsequent detection in neurons by in situ hybridization. VZV was also reported to be reactivated from ganglion cells from these rats upon trypsinization and cocultivation with permissive fibroblasts (14) . These findings seem surprising because the rat is not readily infected by VZV. Moreover, their relevance to latency in man is uncertain.
We have investigated an in vitvo model of VZV latency, based on an in vitro model of HSV latency, which appears to mimic many of the features of HSV latency noted in humans and infected animals (15) . In this HSV model, dissociated DRG neuronal cultures prepared from rat or human fetuses are infected with HSV in the presence of NGF, and acyclovir is included to limit productive infection. Acyclovir is removed 7 d after infection. HSV-latent infection, as indicated by the absence of infectious virus or viral antigens, is maintained as long as cultures are maintained in the presence of NGF. The tissue was obtained from already-scheduled therapeutic with PBS. Avidin-biotin horseradish peroxidase complex was abortions. Written, informed consent was obtained for use of the added for 30 rnin and washed with PBS, and the bound peroxifetal tissue for scientific purposes. The DRG was dissected from dase activity was detected with diaminobenzidine in the presence the spinal cord and enzymatically digested for 30 rnin at 37°C of Hz02 and nickel chloride (Vector DAB Substrate Kit; Vector with 1 mg/mL of collagenase (Boehringer Mannheim Diagnos-Laboratories). The cells were counterstained with hematoxylin. tics, Inc., Indianapolis, IN) in L-15 medium (Gibco Laboratories, Radioactive Labeling of Neuronal Proteins and ZmmunopreGrand Island, NY). DRG were rinsed with L-15 medium con-cipitation. Cultures were placed in methionine-free minimal taining 5% newborn calf serum, mechanically dissociated in essential medium for 60 min and then labeled with [35S]methi-EMEM, and plated onto 24-well multidishes coated with rat-tail onine (300 pCi/mL; sp act > 1000 Ci/mol; Amersham Corp., collagen.
Arlington Heights, IL) for 3 h at 37°C. They were washed three Neuronal cultures were maintained in EMEM containing 10% times with PBS and disrupted in 4 mL of lysis buffer (0.02 M newborn calf serum and 50 ng/mL mouse 2.5s NGF. Neuronal sodium phosphate, pH 7.6,O.l M NaCl, 1% Triton X-100,0.5% cultures were treated with 20 pM FUDR (Sigma, St. Louis) for deoxycholate, 0.1 % SDS). The lysates were kept on ice for 2 h 7-10 d after plating to inhibit growth of nonneuronal cells (15, and centrifuged at 40 000 rpm in a Beckman SW60 rotor for 2 16). FUDR was removed 12 h before virus inoculation. Wells h at 5°C. Supernatants were stored at -70°C. Cell lysates (0.5-typically contained 1 x lo4 neurons. NGF was present in the 0.7 mL) were subsequently incubated for 2 h at 4°C with 30 pL medium unless otherwise indicated.
of a 10% formalin-fixed suspension of protein A-containing Satellite cell cultures. DRG were harvested as described above, Staphylococcus aureus Cowan I (22) . After centrifugation in a but the cells were maintained in DMEM plus 10% FCS in the microfuge at 4°C for 5 min, VZV-specific proteins were immuabsence of NGF and treated with cytosine arabinoside (10 pg/ noprecipitated at 4°C for 16 h by incubation with MAb (50-100 mL) for 48 of every 96 h to inhibit growth of fibroblasts (16) . pL) prepared against VZV-encoded glycoproteins: gp I, gp 11, Seven to 10 d after plating, 35-50% of the cells stained with and gp IV (23) . Finally, 30 wL of a 10% formalin-fixed S. aureus antibody against S-100 antigen. This is the percentage of non-was added, and after 2 h at 4"C, absorbed immune complexes neuronal cells that stain positively for S-100 antigen in sections were washed three times with lysis buffer and suspended in 20 of human ganglia harvested at autopsy (unpublished results). The pL of TNE buffer (50 mM Tris-HC1, pH 7.4, 150 mM NaC1, 5 S-100 antigen staining probably underestimates the actual num-mM EDTA). After addition of 10 pL of 3x sample buffer (150 ber of satellite cells in the tissue culture because the expression mM Tris-HC1, pH 7.0, 6% SDS, 15% 2-mercaptoethanol, 0.01% of this antigen varies with the stages of differentiation (17, 18) . bromophenol blue), the suspension was heated in boiling water The other cells in this culture have the morphologic appearance, for 4 min, cooled on ice, and analyzed by 10% SDS-PAGE as using low-magnification microscopy, of fibroblasts; no neurons described previously (24) . were evident.
Electrophoresis was carried out for 16 h at 50 V per gel at Mixed (neurons and satellite cells) culture. DRG cells were room temperature. The gels were stained with 50% methanol/ treated with EMEM plus 10% FCS and NGF. FUDR was added 7% acetic acid/2% Coomassie brilliant blue and destained in for 48 of every 96 h and removed before virus inoculation.
10% methanol/7% acetic acid. Gels were processed for fluorog-DRG-derived fibroblasts. DRG cells were maintained with raphy (En3Hance; New England Nuclear Corp., Boston, MA), DMEM supplemented with 10% FCS. Confluent monolayers dried, and exposed to Kodak X-Omat AR film at -70°C. were trypsinized and passed three times. Fibroblasts were the only cell type apparent in final cultures. (19) . Cells were to 96 h (Fig. I) , as demonstrated previously (16) . The CPE was infected with 0.5-1.0 pfu/cell of VZV in the presence of BVaraU. similar to that seen with VZV infection of other human cell Seven d after infection, the antiviral agent was removed by types, and the infected cells stained positively for VZV immediwashing the culture five times with 1.0 mL of medium. The ate-early (Fig. 2B ) and late antigens (data not shown). Lysates medium was changed every 2-3 d. from each of the acutely infected neural cell types contained VZV reactivation. Seven to 21 d after removal of BVaraU VZV proteins detectable by immunoprecipitation (neurons (214 d after infection), cells were trypsinized and added to shown, Fig. 3B ; other types not shown). monolayers of HELF. Cells were inspected daily for 7 d; if there VZV infection ofDRG-derived cells in thepresence of BVaraU. was no CPE, they were trypsinized and blindly passed to fresh As expected, BVaraU (2.9 pM) completely prevented lytic infec-HELF monolayers for an additional 14 d. In some experiments, tion. After removal of BVaraU and NGF, however, no CPE was the cell suspensions were sonicated, as described above for the observed, and no VZV antigens were detected during an obser-VZV inoculum, before addition to HELF. An alternate proce-vation period of 7 to 21 d (Figs. 2 C and 3C) . In control experidure for reactivation was the addition of HELF directly to the ments, to exclude persistence of BVaraU in cells, uninfected cells neuronal cell cultures. The HELF cultures were inspected for 2 1 were treated with BVaraU and washed as described for the model; d for CPE and studied by immunohistochemistry or immuno-these cells were capable of supporting VZV replication to the precipitation for the presence of VZV antigen. same extent as untreated monolayers. Furthermore, the medium Staining for VZV immediate-early and late proteins. Cell left after the extensive washing procedure contained no residual monolayers grown on glass coverslips were fixed with methanol/ inhibitory effect on VZV as assayed in HELF or in neural cells. acetone (1 : 1) for 10 min at -20°C, air dried, and stored at -20°C.
VZV infection of neuronal cultures.
BVaraU at a 10-fold lower concentration (0.29 pM) similarly For antigen staining, the coverslips were treated for 20 min at prevented lytic infection without evidence of VZV replication room temperature with 1.5% normal horse serum in PBS, after its removal. washed with PBS, and reacted with a monoclonal murine antiReactivation of VZV. Attempts to recover virus by cocultiva- Fig. 3 0 are occasionally seen in cells infected with VZV and harvested at various time periods after infection). Before cocultivation, the cultures did not contain infectious virions, because sonication of the cells yielded no plaques when the lysates were added to permissive cell monolayers ( Table 1 ). The rate of VZV recovery after sonication under conditions used in these experiments was one cell-free infectious virion for every twelve infectious centers present in the culture before sonication. VZV reactivation was not influenced by the presence or absence of NGF after removal of BVaraU (data not shown).
DISCUSSION
The mechanism of VZV latency and reactivation is unclear. A major obstacle to an understanding of VZV latency is the lack of reproducible in vitro or in vivo models that mimic natural infection. VZV is fastidious and difficult to work with in the laboratory; its ability to infect nonhuman tissues and small mammals is very limited.
Our attempt to establish an in vitro model of VZV latency is based on a similar HSV model (1 5). Our experiments, however, differed in several respects from those of Wilcox et al. First,
BVaraU was used to inhibit VZV replication, inasmuch as BVaraU is a far more potent inhibitor of VZV than is acyclovir (19) . Secondly, nonneuronal cells were included in the experiment because of evidence indicating that such cells may be sites of latency for VZV (8) and HSV (25) . Finally, reactivation was not influenced by the presence or absence of NGF. Each of the neural cell types studied was readily infected with VZV ( Fig. 1) (16) , but VZV replication was completely inhibited by BVaraU. Removal of BVaraU from infected cultures after 7 d did not result in spontaneous VZV reactivation. Typical CPE and VZV-associated antigen expression were not detected during 7-21 d of observation after removal of BVaraU. The lack of VZV expression during this observation period was not due to persistence of BVaraU in the medium for several reasons: 1) the median infective dose of BVaraU for VZV, as tested in our laboratory, is at least 100-fold higher in neurons than in HELF (unpublished data); 2) when we used a lower concentration of BVaraU (0.29 pM), the same results were obtained; 3) cultures were washed exhaustively and refed periodically; 4) the medium left after the washing procedure did not inhibit VZV replication in HELF or in neural cells; 5 ) BVaraU-treated cells, which were washed and maintained as described for the model, were capable of being infected with VZV; and 6) individual cell types did not yield VZV, whereas mixed cultures maintained under the same conditions did yield VZV.
The cultures did not contain infectious virus, as demonstrated by the failure to recover VZV after sonication. In our reconstruction experiments, the recovery of VZV with the sonication conditions used was 8.5%. Therefore, the probability, by chance alone, of not recovering complete virions present in these cultures at the time of sonication is 11/12 for each virion. However, because we routinely recovered more than 10 pfu/well after successful reactivation attempts with mixed neuronal and satel- lite cells and attempted recovery after sonication from 10 separate wells, the probability of losing all the virions by sonication alone in 10 different wells is (1 1 10/1210)'0 = 0.00017.
When mixed cultures containing both neurons and satellite cells were cocultivated with permissive HELF cells, VZV was recovered (Table 1) . This occurred most frequently (56%) when the cultures were trypsinized before passage to permissive HELF monolayers. VZV was not recovered when the initial infection was undertaken in fibroblasts, neurons, or satellite cells alone. Successful reactivation from mixed cultures could be achieved as long as 2 1 d after removal of BVaraU.
A unique feature of these experiments was the reactivation of VZV only from mixed cultures of neurons and satellite cells but not from the individual cell cultures studied. Satellite cells provide mechanical support for neurons and influence the metabolism and microenvironment of ganglionic neurons (26) . These cells proliferate in vitro in response to neuronal damage (27) . In addition, they enhance neuronal survival, growth, and neurotransmitter content (28) . We speculate that an interaction between neurons and these nonneuronal cells is required to establish and/or maintain the persistence of VZV in our model, and This concept is supported by the findings of Sadzot-Delavaux et al. (14) . In their in vivo rat model of VZV latency, VZV could be recovered from DRG only after trypsinization and not simply after cocultivation of the DRG in permissive cells. There are also clinical observations that may reflect an enhanced proclivity of VZV to reactivate after disruption of neuron-satellite cell interactions. For example, herpes zoster occurs with an increased incidence within X-irradiated dermatomes or within or contiguous to dermatomes containing certain tumors (29-3 1).
The present model appears to represent the establishment and, at least briefly, maintenance of a unique VZV infection. Based on current information, this model functionally mimics the features of latent VZV infection in humans; namely, the absence of viral replication or infectious virions in the tissue with putative latent infection, the absence of gene products in these tissues, and the potential for reactivation of the latent VZV. Further studies are necessary to characterize the pattern of genome expression and to determine whether the viral transcript pattern in the in vitro model resembles that which is emerging from ongoing studies of naturally infected human ganglia (8) .
